• Corpus ID: 29935324

Dry Eye Syndrome Limited Revision

@inproceedings{Feder2011DryES,
  title={Dry Eye Syndrome Limited Revision},
  author={Robert S. Feder and Chair and Steven P. Dunn and Matthew R. Jones and Francis S. Mah and Leslie A Olsakovsky and Audrey R. Talley-Rostov and Andrew J. Velazquez and David C. Musch and Christopher J. Rapuano and David F Chang and Emily Y. Chew and Stephen D. McLeod and Bruce E. Prum and Geoffrey D. Summers and Nancy Collins},
  year={2011}
}
eyenet.com.cn
1 Citations

Figures and Tables from this paper

One Citation

Citation Type

Citation Type

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.

References

SHOWING 1-10 OF 118 REFERENCES
Anxiety and Depression in Patients with Dry Eye Syndrome
TLDR
Anxiety and depression are correlated with dry eye syndrome, demonstrating that DES is an important public health problem that merits increased attention and research.
Pilot, Prospective, Randomized, Double-masked, Placebo-controlled Clinical Trial of an Omega-3 Supplement for Dry Eye
TLDR
Dietary supplementation with omega-3 fatty acids in dry eye showed no significant effect in meibum lipid composition or aqueous tear evaporation rate, but the average tear production and tear volume was increased in the omega- 3 group as indicated by both Schirmer testing and fluorophotometry.
Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615-21
  • Dry Eye Syndrome 2011 P.O. Box 7424
  • 2011
Tear osmolarity in the diagnosis and management of dry eye disease.
The Association of Meibomian Gland Dysfunction and Other Common Ocular Diseases With Dry Eye: A Population-Based Study in Spain
TLDR
The relationship of meibomian gland dysfunction and other prevalent ocular diseases with dry eye (DE) in a general adult population is investigated to find MGD is strongly associated with symptoms and signs of DE.
Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
and Drug Administration, Center for Drug Evaluation and Research
  • Restasis (cyclosporine ophthalmic emulsion) 0.05% sterile, preservative-free. NDA 50-790/S-001. 2003:6. Available at: www.accessdata.fda.gov/drugsatfda_docs/label/2003/50790slr001_restasis_lbl.pdf. Accessed May 4,
  • 2011
Associations between Gender, Ocular Parameters and Diseases: The Beijing Eye Study
TLDR
Female gender was significantly associated with a shallower anterior chamber and narrower anterior chamber angle, higher prevalence of dry eye, and with the systemic parameters of lower educational level, rural region, smoking and alcohol consumption.
Efficacy of Hydroxypropyl Cellulose Ophthalmic Inserts (LACRISERT) in Subsets of Patients With Dry Eye Syndrome: Findings From a Patient Registry
TLDR
In subsets of patients with moderate to severe DES and comorbid conditions, hydroxypropyl cellulose ophthalmic inserts improve the symptoms of DES, ability to perform ADLs, and quality of life.
Improved Signs, Symptoms, and Quality of Life Associated With Dry Eye Syndrome: Hydroxypropyl Cellulose Ophthalmic Insert Patient Registry
TLDR
Hydroxypropyl cellulose ophthalmic inserts significantly improved signs and symptoms of moderate-to-severe DES, as well as ADL and QoL, and benefits were additive to those seen with patients' existing care.
...
1
2
3
4
5
...